OverviewSuggest Edit

BeyondSpring is a clinical-stage biopharmaceutical company. It develops immuno-oncology cancer therapies and offers a drug development pipeline which includes a variety of Plinabulin products. The company also provides a preclinical immuno-oncology pipeline that includes BPI-002, BPI-003, and BPI-004 programmes.

TypePublic
Founded2010
HQNew York, US
Websitebeyondspringpharma.com
Employee Ratings1.3

Latest Updates

Employees (est.) (Dec 2018)52(+37%)
Share Price (Nov 2019)$12.5 (-4%)

Key People/Management at BeyondSpring

Lan Huang

Lan Huang

Co-Founder and Chairman, CEO
Ramon Mohanlal

Ramon Mohanlal

EVP, Research and Development, Chief Medical Officer
Richard Daly

Richard Daly

COO
Kenneth Lloyd

Kenneth Lloyd

Chief Scientific Officer
Gordon Schooley

Gordon Schooley

Chief Regulatory Officer
Edward Dongheng Liu

Edward Dongheng Liu

CFO
Show more

BeyondSpring Office Locations

BeyondSpring has an office in New York
New York, US (HQ)
28 Liberty St 39th Floor
Show all (1)

BeyondSpring Financials and Metrics

BeyondSpring Revenue

USD

Net income (H1, 2019)

(15.4m)

EBIT (H1, 2019)

(15.3m)

Market capitalization (29-Nov-2019)

346.3m

Closing stock price (29-Nov-2019)

12.5

Cash (30-Jun-2019)

674.0k

EV

351.3m
BeyondSpring's current market capitalization is $346.3 m.
Annual
USDFY, 2016FY, 2017FY, 2018

General and administrative expense

1.9m9.1m5.9m

R&D expense

10.4m88.9m51.6m

Operating expense total

12.4m98.0m57.5m

EBIT

(12.4m)(98.0m)57.5m
Half Year
USDH1, 2017H1, 2018H1, 2019

General and administrative expense

3.9m2.1m3.8m

R&D expense

58.9m25.1m11.5m

Operating expense total

62.8m27.2m15.3m

EBIT

(62.8m)(27.2m)(15.3m)
Annual
USDFY, 2016FY, 2017FY, 2018

Cash

11.7m27.5m3.9m

Prepaid Expenses

360.0k264.0k292.0k

Current Assets

14.7m32.3m5.9m

PP&E

80.0k123.0k282.0k
Half Year
USDH1, 2017H1, 2018H1, 2019

Cash

49.0m19.4m674.0k

Prepaid Expenses

338.0k525.0k167.0k

Current Assets

50.8m24.8m2.0m

PP&E

87.0k116.0k237.0k
Annual
USDFY, 2016FY, 2017FY, 2018

Net Income

(12.5m)(96.4m)(57.5m)

Depreciation and Amortization

18.0k32.0k48.0k

Accounts Payable

144.0k2.9m6.2m

Cash From Operating Activities

(13.7m)(28.8m)(40.0m)
Half Year
USDH1, 2017H1, 2018H1, 2019

Net Income

(62.6m)(26.9m)(15.4m)

Depreciation and Amortization

13.0k20.0k41.0k

Accounts Payable

1.6m(575.0k)(1.1m)

Cash From Operating Activities

(10.4m)(22.0m)(13.1m)
USDY, 2019

EV/EBIT

-22.9 x

EV/CFO

-26.8 x

Debt/Equity

-0.3 x

Debt/Assets

0.9 x

Financial Leverage

-0.3 x
Show all financial metrics

BeyondSpring Operating Metrics

FY, 2016FY, 2017FY, 2018

Patents Issued

17 17 20

Phase I Trials Products

1 2 2

Phase II Trials Products

2 1

Phase III Trials Products

1 2 3
Show all operating metrics

BeyondSpring Acquisitions / Subsidiaries

Acquired CompanyDateDeal Size
Beijing Wanchun Pharmaceutical Technology 
BeyondSpring (HK) Limited
BeyondSpring LTD.
BeyondSpring Pharmaceuticals Inc.
BeyondSpring Pharmaceuticals Australia PTY 
Dalian Wanchunbulin Pharmaceuticals Ltd.
Wanchun Biotechnology Limited
Wanchun Biotechnology (Shenzhen) Ltd.

BeyondSpring Online and Social Media Presence

Embed Graph

BeyondSpring Blogs

BeyondSpring’s Single-Blinded Design (for Patients Only) of Phase 3 Study 103 (DUBLIN-3) Prevented Premature Patient Drop-Out: Data Accepted for Presentation at SITC 2019

Premature Patient Drop-Out Rate from Comparator Arm Might Contribute to Negative Trial Outcome, and was Avoided in DUBLIN-3 NEW YORK , Nov. 11, 2019 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI), a global biopharmaceutical company focused on the development of innovative immuno-oncology

BeyondSpring Appoints Gregg Russo as Senior Vice President, Human Resources

NEW YORK , Nov. 06, 2019 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI), a global biopharmaceutical company focused on the development of innovative immuno-oncology cancer therapies, today announced that the Company has appointed Gregg Russo as Senior Vice President, Human Resources,

BeyondSpring Announces Pricing of Ordinary Shares

NEW YORK , Oct. 25, 2019 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (the “Company” or “BeyondSpring”) (Nasdaq: BYSI), a global clinical stage biopharmaceutical company focused on the development and commercialization of innovative immuno-oncology cancer therapies, today announced the pricing of its

BeyondSpring Announces Proposed Public Offering of Ordinary Shares

NEW YORK , Oct. 24, 2019 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (the “Company” or “BeyondSpring”) (Nasdaq: BYSI), a global clinical stage biopharmaceutical company focused on the development and commercialization of innovative immuno-oncology cancer therapies, today announced the launch of an

BeyondSpring Enrolls First Patient in Global Phase 3 Clinical Trial with Plinabulin in combination with G-CSF to Prevent Chemotherapy-Induced Neutropenia

BeyondSpring Enrolls First Patient in Global Phase 3 Clinical Trial with Plinabulin in combination with G-CSF to Prevent Chemotherapy-Induced Neutropenia Content Import Wed, 10/23/2019 - 08:01 BeyondSpring Enrolls First Patient in Global Phase 3 Clinical Trial with Plinabulin in combinatio…

BeyondSpring’s Lead Asset, Plinabulin, Granted U.S. Patent Covering Methods of Treating Brain Tumors

BeyondSpring’s Lead Asset, Plinabulin, Granted U.S. Patent Covering Methods of Treating Brain Tumors Content Import Thu, 10/17/2019 - 08:01 BeyondSpring’s Lead Asset, Plinabulin, Granted U.S. Patent Covering Methods of Treating Brain Tumors Oct 17,2019 This re…
Show more

BeyondSpring Frequently Asked Questions

  • When was BeyondSpring founded?

    BeyondSpring was founded in 2010.

  • Who are BeyondSpring key executives?

    BeyondSpring's key executives are Lan Huang, Ramon Mohanlal and Richard Daly.

  • How many employees does BeyondSpring have?

    BeyondSpring has 52 employees.

  • Who are BeyondSpring competitors?

    Competitors of BeyondSpring include TESARO, Omeros and Athersys.

  • Where is BeyondSpring headquarters?

    BeyondSpring headquarters is located at 28 Liberty St 39th Floor, New York.

  • Where are BeyondSpring offices?

    BeyondSpring has an office in New York.

  • How many offices does BeyondSpring have?

    BeyondSpring has 1 office.